Controlled Drugs and Substances Act & Regulations

Food and Drugs Act & Regulations

Amendments:

To the Food and Drug Regulations

Pre-notifications

Regulations Amending the Food and Drug Regulations (1447 - Good Manufacturing Practices) (October 11, 2006)
Amendment to the Food and Drug Regulations, Project No. 743, Non-medicinal Ingredients (August 14, 2006)
Regulations Amending the Food and Drug Regulations (1390 - Data Protection)
Regulations Amending the Food and Drug Regulations (1422 - Schedule F)
Regulations Amending the Food and Drug Regulations (1384 - Schedule F)
Regulations Amending the Food and Drug Regulations (1383 - Schedule F)
Regulations Amending the Food and Drug Regulations (1381 - Schedule F)
Regulations Amending the Food and Drug Regulations (1367 - Schedule F)
Regulations Amending the Food and Drug Regulations (1421 - Schedule F)
Notice of Intent to Develop Environmental Assessment Regulations for Products Regulated under The Food and Drugs Act

Canada Gazette - Part I

Canada Gazette - Part II

To Schedule F

Pre-notifications

Project #1621 Proposed Additon of 4 Medicinal Ingredients (Dirlotapide, Firocoxib, Ibafloxacin and Maripotant and its salts) to Schedule F (February 2, 2010)
Project #1624 Proposed Addition of 4 Medicinal Ingredients (Eculizumab, Olmesartan medoxomil, Romiplostim and Ustekinumab) to Schedule F (January 11, 2010)
Project #1652 Notice of Intent to Amend Schedule F (L-asparaginase) (December 24, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Dronedarone to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Degarelix to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Clofarabine to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Azacitidine to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Urokinase to Schedule F (December 10, 2009)
Project #1658 Proposed Addition of Medicinal Ingredient Doripenem and its salts and derivatives (December 10, 2009)
Project #1658 Proposed Addition of Medicinal Ingredient Besifloxacin and its salts to Schedule F (December 10, 2009)
Project #1658 Proposed Addition of Medicinal Ingredient Alitretinoin and its salts and derivatives to Schedule F (December 10, 2009)
Project #1658 Proposed Addition of Medicinal Ingredient Saxagliptin and its salts to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Certolizumab Pegol to Schedule F (October 5, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Aripiprazole and its salts (October 5, 2009)
Project #1597 Proposed Addition of 3 medicinal ingredients (Idebenone, Idursulfase, Nesiritide) to Schedule F (October 1, 2009)
Project #1623 Proposed Addition of 4 medicinal ingredients (Desvenlafaxine and its salts, Eplerenone, Fosaprepitant and its salts and Moclobemide) to Schedule F (September 24, 2009)
Project #1625 RESCINDED Medical Ingredient Hyoscine and its salts and derivatives (September 1, 2009)
Project #1623 REVISED Medicinal Ingredient Fosaprepitant and its salts to Schedule F (July 15, 2009)
Project #1623 REVISED Medicinal Ingredient (Eplerenone) to Schedule F (July 15, 2009)
Project #1623 REVISED Medicinal Ingredient (Desvenlafaxine and its salts) to Schedule F (July 15, 2009)
Project #1627 Proposed Addition of 1 Medicinal Ingredient (Vorinostat) to Schedule F (June 26, 2009)
Project #1627 Proposed Addition of 1 Medicinal Ingredient (Golimumab) to Schedule F (June 09, 2009)
Project #1627 Proposed Addition of 1 Medicinal Ingredient (Lapatinib and its salts) to Schedule F (June 09, 2009)
Project #1626 Proposed Addition of 1 Medicinal Ingredient (Collagenase) to Schedule F (June 10, 2009)
Project #1625 Proposed Addition of 1 Medicinal Ingredient (Hyoscine and its salts and derivatives) to Schedule F (June 9, 2009)
Project #1624 Proposed Addition of 1 Medicinal Ingredient (Ustekinumab) to Schedule F (May 15, 2009)
Project #1624 Proposed Addition of 1 Medicinal Ingredient (Romiplostim) to Schedule F (May 15, 2009)
Project #1623 Proposed Addition of 4 Medicinal Ingredients (Aprepitant and its salts and derivatives, Moclobemide, Spironolactone and its derivatives, and Venlafaxine and its salts and derivatives) to Schedule F (May 12, 2009)
Project #1624 Proposed Addition of 1 Medicinal Ingredient (Olmesartan medoxomil) to Schedule F (May 11, 2009)

Project #1597 Proposed Addition of 1 Medicinal Ingredient (Idursulfase) to Schedule F (February 17, 2009)
Project #1597 Proposed Addition of 1 Medicinal Ingredient (Nesiritide) to Schedule F (February 17, 2009)
Project #1597 Proposed Addition of 1 Medicinal Ingredient (Idebenone) to Schedule F (December 9, 2008)
Project #1578 Proposed Addition of 1 Medicinal Ingredient (Acamprosate) to Schedule F (November 15, 2007)
Project #1441: Proposed Addition of 1 Medicinal Ingredient (Zaleplon) to Schedule F (August 17, 2006)
Project #1431: Proposed Addition of 1 Medicinal Ingredient (Quinine and its salts and derivatives) to Schedule F (May 29, 2006)
Project #1405: Proposed Addition of 7 Medicinal Ingredients (Atazanavir and its salts; Fulvestrant; Gefitinib; Gemifloxacin and its salts; Hetastarch and its derivatives; Ibandronic acid and its salts; Ponazuril) to Schedule F (November 15, 2005)
Schedule 1397: Schedule F Update (January 2004)

Canada Gazette - Part I

Project #1554: Proposed Addition of one medicinal ingredient, (Progesterone and its derivatives except when sold in an implant for veterinary use for growth promotion) (January 19, 2008)
Schedule 1385: Vitamin K (January 2004/April 2005)
Schedule 1203: Addition of nine new drug substances (Feburary 2000)
Zaleplon, Zolpidem, Zopiclone (June 29/02)

Canada Gazette Part II

To the Natural Health Products Regulations

Canada Gazette - Part II

Regulations Amending the Natural Health Products Regulations (Vitamin K) (October 19, 2005)
Regulations amending the NHPR (Special Access) - June 2004

Related Documents